Vicarious Surgical (RBOT) Scheduled to Post Quarterly Earnings on Monday

Vicarious Surgical (NYSE:RBOTGet Free Report) will issue its quarterly earnings data after the market closes on Monday, April 29th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Vicarious Surgical (NYSE:RBOTGet Free Report) last posted its quarterly earnings results on Monday, March 4th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.05. During the same period in the previous year, the company earned ($0.16) EPS. On average, analysts expect Vicarious Surgical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Vicarious Surgical Price Performance

RBOT opened at $0.27 on Friday. Vicarious Surgical has a fifty-two week low of $0.20 and a fifty-two week high of $2.46. The business has a 50-day moving average of $0.33 and a 200-day moving average of $0.37. The company has a market capitalization of $47.45 million, a PE ratio of -0.55 and a beta of 1.18.

Analyst Ratings Changes

Separately, Piper Sandler cut their price target on Vicarious Surgical from $1.50 to $1.00 and set a “neutral” rating for the company in a research note on Tuesday, March 5th.

View Our Latest Research Report on RBOT

Vicarious Surgical Company Profile

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Featured Articles

Earnings History for Vicarious Surgical (NYSE:RBOT)

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.